Urinalysis Market to Grow with a CAGR of 7.67% through 2030
Rising cases of urinary tract infections and increased
research and development for diagnosis is expected to drive Global Urinalysis
Market in the forecast period, 2026-2030.
According to TechSci Research report, “Urinalysis Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, the Global
Urinalysis Market stood at USD 4.39 billion in 2024 and is anticipated to
grow with a CAGR of 7.67% in the forecast period. This
can be attributed to the rising prevalence of kidney disease, diabetes, and
urinary tract infections. Increasing prevalence of Chronic kidney disease
globally is increasing the demand for improved diagnosis and treatments
(including urine examinations) and research worldwide. For instance, according
to the Centers for Disease Control and Prevention report, in United States
kidney disease is the leading cause of death with approximately 37 million US
adults suffering from chronic kidney disease (including the underdiagnosed
patients). Moreover, the burden of diabetes and high blood pressure is highest
cause leading to kidney failure in the country.
Meanwhile, other factors such as, growing focus on disease
screening and increasing government investments and awareness for disease
diagnosis are anticipated to bolster the market growth in the forecast period.
Browse over XX market data Figures spread through XX Pages and an
in-depth TOC on "Global Urinalysis Market.”
Global Urinalysis Market is segmented into product, test
type, application, end user, regional distribution, and company.
Based on Product, the instruments segment is anticipated to
witness the fastest growth in the coming years, propelled by the increasing
introduction and approval of new technologies in the market. Companies are
actively innovating to develop user-friendly, high-performance instruments for
urinalysis. For instance, Withings recently unveiled a compact, in-home
biomarker analysis device called U-Scan, which offers convenient monitoring of
urine health data through integration with a mobile health app. Similarly,
Sysmex Europe SE launched the UF-1500, an advanced automated urine particle
analyzer that utilizes fluorescence flow cytometry for detailed and efficient
detection of urinary tract infections. These advancements highlight the growing
preference for automated and smart diagnostic solutions, reinforcing the strong
growth outlook for the instruments segment in urinalysis.
Based on the Region, Asia Pacific demonstrates the fastest
growth in the global urinalysis market. This rapid expansion is driven by
several interconnected factors, including a rising population, increasing
burden of chronic diseases, improving healthcare infrastructure, and growing
government initiatives aimed at enhancing diagnostic capabilities. Countries
across the region, such as China, India, and Southeast Asian nations, are
witnessing a surge in demand for diagnostic tests due to the increasing prevalence
of conditions like diabetes, kidney disease, and urinary tract
infections. The demographic shift toward an aging population in many Asia
Pacific countries is significantly contributing to this demand. Older adults
are more likely to suffer from chronic conditions requiring regular monitoring
through urinalysis, which supports the consistent growth of the market.
Moreover, the increasing awareness among patients and healthcare providers
about the importance of early disease detection is further encouraging the use
of routine urine testing in both urban and rural settings.
Major companies operating in the Global Urinalysis Market
are:
- F.
Hoffmann-La Roche Ltd
- Siemens
Healthineers AG
- Abbott
Laboratories
- Cardinal
Health Inc.
- Danaher
Corporation
- Sysmex
Corporation
- Quidel
Corporation
- Becton,
Dickinson & Company
- Bio-Rad
Laboratories Inc.
- EKF
Diagnostics Holdings plc
Customers can also request for 10% free customization
on this report.
“Strong government support in the form of healthcare funding, public health
programs, and regulatory approvals for advanced diagnostic tools has further
contributed to market development. Authorities across the region are actively
promoting the adoption of early screening tests and point-of-care diagnostics
as part of broader initiatives aimed at reducing long-term treatment costs and
improving patient outcomes. This is complemented by the presence of
well-established diagnostic manufacturers and research institutions, which
continue to introduce innovative urinalysis solutions tailored to clinical
needs.” said Mr. Karan Chechi, Research Director of TechSci Research, a
research based global management consulting firm.
"Urinalysis Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Product (Consumables, Instruments), By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), By Application (Disease Screening, Pregnancy & Fertility), By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, Research Laboratories & Institutes), By Region and Competition, 2020-2030F”, has
evaluated the future growth potential of Urinalysis Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global urinalysis Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com